| Pharmaceutical active ingredients: |
| HydrochlorothiazideLosartan Potassium |
| Available forms, composition and doses of Ocsaar Plus: |
| Tablets; Oral; Hydrochlorothiazide 12.5 mg; Losartan Potassium 50 mg |
| Ocsaar Plus medical category: |
| Human:Angiotensin II receptor antagonistsThiazide diuretics |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C03AX01 - Hydrochlorothiazide, combinationsC09DA01 - Losartan and diuretics |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Merck |
| Related documents and information about Ocsaar Plus: |
| Ocsaar prescribing information (PDF)Ocsaar Plus prescribing information (PDF) |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Neopress | Hydrochlorothiazide; Losartan Potassium | Neo Quimica Comercio e Industria Laboratorio |
| Neosartan Plus | Hydrochlorothiazide; Losartan Potassium | GX International; Metro Drug Distribution |
| Nipartan-H | Hydrochlorothiazide; Losartan Potassium | Micro Labs; Brown & Burk Pharmaceuticals |
| Niten D | Hydrochlorothiazide; Losartan Potassium | IVAX |
| Nusar-H | Hydrochlorothiazide; Losartan Potassium | Emcure Pharmaceuticals |
| Omnitan H | Hydrochlorothiazide; Losartan Potassium | Macleods Pharmaceuticals |
| Osart-H | Hydrochlorothiazide; Losartan Potassium | Invision Medi Sciences |
| Paxon-D | Hydrochlorothiazide; Losartan Potassium | Gador |
| Presinor D | Hydrochlorothiazide; Losartan Potassium | Lafedar Laboratorios |
| Repace-H | Hydrochlorothiazide; Losartan Potassium | Sun Pharmaceutical Industries |